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BY-NC-ND license (http://creativecoSummary Background: Among several minimally invasive adrenalectomy techniques, lateral
transperitoneal adrenalectomy (LTA) is the procedure of choice for benign adrenal tumors;
however, posterior retroperitoneoscopic adrenalectomy (PRA) is an alternative that is
increasing in popularity. This study compared the outcomes of these two approaches.
Methods: Since a single surgeon started adrenalectomy, LTA had been performed exclusively
until PRA was adopted and became the standard treatment. Therefore, the consecutive pa-
tients were allocated into two groups according to the date of surgery: the first group received
LTA and the second group received PRA.
Results: LTA was performed in 29 patients and PRA in 19 patients. There was no difference in
sex, age, body mass index, clinical diagnosis, and tumor size between the LTA and the PRA
group. The PRA group showed less blood loss (117.0 mL vs. 58.5 mL, p Z 0.035) and tended
to have a shorter operating time (92.2 minutes vs. 78.1 minutes, pZ 0.054) and less pain score
on postoperative Day 1 (3.8 vs. 3.0, p Z 0.095) and Day 2 (3.2 vs. 2.5, p Z 0.051). The mean
operation time was significantly shorter for patients in the PRA group undergoing right adrenal-
ectomy (109.2 minutes vs. 80.5 minutes, pZ 0.009), but those undergoing left adrenalectomyave no conflicts of interest or financial ties to disclose.
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Comparative study of LTA and PRA 75had a similar operating time to the LTA group (83.2 minutes vs. 74.8 minutes, p Z 0.380).
Conclusion: PRA is a good alternative operative technique for an endocrine surgeon who is
experienced in the transperitoneal approach.
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access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Since Gagner and colleagues’1 report of its successful use
for the treatment of Cushing’s disease and pheochromo-
cytoma in 1992, laparoscopic transperitoneal adrenalec-
tomy (LTA) has been the gold standard treatment for benign
adrenal tumors. Its benefits over open adrenalectomy were
demonstrated in subsequent studies.2e4 However, since its
introduction in 1996 (along with improvements in laparo-
scopic instruments and surgical techniques), posterior
retroperitoneal adrenalectomy (PRA) is regarded as a bet-
ter approach for small benign adrenal tumors.5
LTA is performed within the peritoneal space with the
patient in the lateral decubitus position, whereas PRA is
performed in the retroperitoneal space with the patient
prone. PRA is safe and unaffected by the presence of intra-
abdominal adhesions, and can also be performed in obese
patients.6e8 Previous studies comparing LTA with PRA
report that PRA has advantages in terms of shorter opera-
tive time, reduced blood loss, reduced length of hospital
stay, less postoperative pain, and a faster return to
work5,9e13; however, variations in the experience of sur-
geons, their individual preference for a particular tech-
nique, and bias in patient selection weaken the impact of
many retrospective comparative studies.
In our institution, an endocrine surgeon always removed
benign adrenal tumors using LTA prior to 2012; however, he
has now exclusively adopted PRA. Therefore, in the present
study, patients were allocated into groups according to the
date of their surgery rather than the surgeon’s preference
for a particular technique. Thus, the present study is the
first to compare the outcomes of LTA and PRA in the
absence of selection bias and surgical experience.
2. Materials and methods
2.1. Patient selection
A single surgeon (K.E.L.) performed minimally invasive
adrenalectomy using LTA technique exclusively at Seoul
National University Hospital from September 2009 until
December 2011. Then the surgeon adopted PRA in January
2012, and it has been performed exclusively until
September 2012. The medical records of all patients who
underwent LTA and PRA performed by the study surgeon at
Seoul National University Hospital, Seoul, Korea from
September 2009 to September 2012 were reviewed. The
inclusion criteria were as follows: patients with a benign
adrenal tumor of <5 cm in diameter on the pathology re-
ports in the case of pheochromocytoma, and those with atumor <7 cm in case of Cushing’s syndrome, aldosteronism,
or for nonfunctioning tumors. The exclusion criteria were
bilateral adrenalectomy or conversion to an open proce-
dure. The study was approved by the Institutional Review
Board of Seoul National University Hospital.2.2. Operative techniques
For LTA, the patient was placed in the lateral decubitus
position with the affected side facing upward and the
operative bed flexed just above the level of the iliac crest.
The laparoscopic procedure was performed through a
transperitoneal approach as described by Duh et al,14
except that three ports were used on the left side and
four on the right (Figure 1).
For PRA, the patient was intubated after anesthesia in a
patient bed and then turned over from the bed onto the
operating table. PRA was performed with the patient in the
prone jackknife position with a moderately bent hip joint.
Routinely, three holes were made along the lower tip of the
12th rib, and the operation was performed as described by
Walz et al.152.3. Outcome evaluation
The operation time was calculated from the time of the
first incision to the closing of the final stitch. Operation
time and blood loss were obtained from the surgeon’s
operation record or from the anesthesia record. An arterial
line was inserted, and blood pressure and heart rate were
monitored and recorded automatically during the opera-
tion. An intraoperative hypertensive event was defined as
systolic blood pressure (SBP)  170 mmHg and an intra-
operative hypotensive event as SBP  90 mmHg or diastolic
blood pressure (DBP)  50 mmHg; the number of these
events was recorded. The tumor size was obtained from
pathology reports.
Pain was evaluated using a visual analog scale (VAS). The
VAS ranges from 0 (no pain) to 10 (worst pain). The VAS was
checked three times a day and expressed as the daily mean
value. Acetaminophen (650 mg) was used routinely for
postoperative pain management. Analgesic injections
(intramuscular ketorolac tromethamine, 30 mg) were pre-
scribed upon patient demand. Sips of water were allowed 6
hours postoperatively, and an oral semi-blended or regular
diet was initiated from postoperative Day 1, regardless of
whether or not the patient had passed gas. Patients who
used patient-controlled analgesia (PCA) were excluded
when evaluating the VAS and analgesic requirements.
Figure 1 (A) Position for left lateral transperitoneal adrenalectomy. (B) Position for posterior retroperitoneoscopic adrenalec-
tomy. (C) Intraoperative view of left lateral transperitoneal adrenalectomy. (D) Intraoperative view of left posterior retro-
peritoneoscopic adrenalectomy. (E) Intraoperative view of right lateral transperitoneal adrenalectomy. (F) Intraoperative view of
right posterior retroperitoneoscopic adrenalectomy.
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All statistical analyses were performed using SPSS version
19 (SPSS Inc., Chicago, IL, USA). Numerical data are pre-
sented as the mean or median and standard deviation.
Comparisons were performed using the Student t test, the
ManneWhitney U test, the Chi-square test, or Fisher’s exact
test as appropriate. A p value <0.05 was considered sta-
tistically significant.
3. Results
A total of 29 LTA and 19 PRA patients were eligible for the
study. Patient demographics and clinical data are shown in
Table 1. There was no significant difference between the
two study groups in terms of gender, age, body mass index,
antihypertensive medication history, preoperative blood
pressure, preoperative heart rate, history of abdominal
surgery, clinical diagnosis, tumor location, or tumor size.The operative outcomes and intraoperative hemody-
namic parameters are shown in Table 2. The mean opera-
tion time for the PRA group was less than that for the LTA
group (92.2  27.0 minutes vs. 78.1  18.9 minutes,
p Z 0.054), although the difference was not statistically
significant. Blood loss was significantly lower in the PRA
group than in the LTA group (117.0  83.4 mL vs.
58.5  58.1 mL, pZ 0.035). The peak SBP was lower in the
PRA group (151.8  26.4 mmHg vs. 138.0  14.2 mmHg,
pZ 0.041), but there were no significant differences in the
lowest SBP, lowest DBP, highest/lowest heart rates, hy-
pertensive/hypotensive events during the operation, or
intraoperative use of inotropic or antihypertensive drugs.
Intraoperative hypertensive events occurred in four LTA
patients. One event occurred once in each of the four pa-
tients and was controlled within 5 minutes either with or
without antihypertensive medication. The highest end tidal
CO2 was significantly greater in the PRA group than in the
LTA group (36.0  2.9 mmHg vs. 40.8  4.7 mmHg,
Table 1 Patient and tumor characteristics.
LTA (n Z 29) PRA (n Z 19) p
Sex 0.835
Male 10 (34.5) 6 (65.5)
Female 19 (65.5) 13 (68.4)
Age (y) 48.6  15.3 45.8  14.4 0.543
Body mass index
(kg/m2)
23.8  2.7 23.5  3.3 0.712
Anti-hypertensive
medication
22 (75.9) 14 (77.8) 1.0
Systolic blood
pressure (mmHg)
133.3  19.9 128.3  13.6 0.336
Diastolic blood
pressure (mmHg)
83.6  18.2 80.8  13.1 0.566
Heart rate 79.8  17.3 75.3  10.6 0.272
History of abdominal
surgery
12 (41.4) 7 (38.9) 0.866
Clinical diagnosis 0.701
Aldosteronism 14 (48.3) 7 (36.8)
Cushing’s syndrome 7 (24.1) 4 (21.1)
Pheochromocytoma 5 (17.2) 6 (31.6)
Nonfunctioning
tumor
3 (10.3) 2 (10.5)
Location of tumor 0.110
Right 10 (34.5) 11 (57.9)
Left 19 (65.5) 8 (42.1)
Mean tumor size (cm) 2.7  1.4 2.9  1.4 0.696
Data are expressed as the n (%) or mean  SD.
LTA Z lateral transperitoneal adrenalectomy; PRA Z posterior
retroperitoneal adrenalectomy.
Table 2 Operative outcomes and intraoperative hemody-
namic parameters in the lateral transperitoneal adrenalec-
tomy (LTA) and posterior retroperitoneal adrenalectomy
(PRA) groups.
LTA (n Z 29) PRA (n Z 19) p
Operation time (min) 92.2  27.0 78.1  18.9 0.054
Blood loss (mL) 117.0  83.4 58.5  58.1 0.035
Intraoperative
highest SBP
(mmHg)
151.8  26.4 138.0  14.2 0.041
Intraoperative lowest
SBP (mmHg)
93.1  14.0 91.0  12.3 0.580
Intraoperative lowest
DBP (mmHg)
57.1  10.7 55.7  10.5 0.672
Intraoperative
highest HR
(beats/min)
82.9  16.2 84.3  19.9 0.787
Intraoperative lowest
HR (beats/min)
57.3  9.2 60.6  13.6 0.316
Intraoperative
highest ETCO2
(mmHg)
36.0  2.9 40.8  4.7 <0.001
Intraoperative
hypertensive
events
(SBP  170 mmHg)
4 (13.8) 0 (0) 0.142
Intraoperative
hypotension
events
(SBP  90 mmHg
or
DBP  50 mmHg)
19 (65.5) 10 (53.6) 0.372
Intraoperative
antihypertensive
drug use
6 (20.7) 2 (10.5) 0.451
Intraoperative
inotropic drug use
3 (10.3) 3 (15.8) 0.669
Data are expressed as n (%) or as mean  SD.
DBP Z diastolic blood pressure; ETCO2 Z end tidal CO2;
HR Z heart rate; SBP Z systolic blood pressure.
Table 3 Mean operation time according to tumor
location.
Right p Left p
LTA PRA LTA PRA
Number of patients 10 11 19 8
Operation time
(min), mean
109.2 80.5 0.009 83.2 74.8 0.380
Body mass index
(kg/m2), mean
23.9 22.9 0.344 23.7 24.3 0.685
Tumor size (cm),
mean
2.6 2.8 0.774 2.8 3.0 0.785
LTA Z lateral transperitoneal adrenalectomy; PRA Z posterior
retroperitoneal adrenalectomy.
Comparative study of LTA and PRA 77p < 0.001). Differences in operation time were more
prominent for those undergoing right adrenalectomy (Table
3): the operation time was significantly shorter for those in
the PRA group (109.2 minutes vs. 80.5 minutes, pZ 0.009),
whereas the operation time for those undergoing left
adrenalectomy was similar to that for the LTA group (83.2
minutes vs. 74.8 minutes, p Z 0.785).
The pain scores for the 24 patients who did not use
patient-controlled analgesia are shown in Table 4. The pain
score on the day of the operation was similar between the
two groups; however, the pain score on the 1st day, 2nd day,
and 3rd day postoperation tended to be lower in the PRA
group than in the LTA group, although the difference was
not statistically significant (3.8  1.4 vs. 3.0  0.8,
pZ 0.095; 3.2  1.1 vs. 2.5  0.7, pZ 0.051; and 2.8  0.8
vs. 2.0  0.6, p Z 0.091, respectively). The analgesic re-
quirements of both groups were similar (PRA, 1.0  0.9
units vs. LTA, 1.2  0.7 units; p Z 0.492). There was no
significant difference in the length of postoperative hospi-
tal stay (PRA, 2.7  0.9 days vs. LTA, 2.9  0.7 days,
p Z 0.558).
There was one case each of morbidity and mortality.
One patient in the PRA group who had a history of chronic
kidney disease suffered acute renal failure for 9 days
postoperation, but recovered after conservative treat-
ment. One patient in the PRA group who had a history of
coronary vessel disease died from acute myocardial
infarction on postoperative Day 8. No patient experienced
nerve root pain.Biochemical markers were tested postoperatively and a
biochemical cure was achieved in all patients with a func-
tioning tumor. No patient suffered recurrence.
Table 4 Postoperative pain score and postoperative
analgesic requirements in the lateral transperitoneal adre-
nalectomy (LTA) and posterior retroperitoneal adrenalec-
tomy (PRA) groups.
LTA
(n Z 11)
PRA
(n Z 13)
p
VAS on Day 0 5.6  1.3 6.2  1.9 0.365
VAS on Day 1 3.8  1.4 3.0  0.8 0.095
VAS on Day 2 3.2  1.1 2.5  0.7 0.051
VAS on Day 3 2.8  0.8
(n Z 3)
2.0  0.6
(n Z 7)
0.091
Postoperative
analgesic
requirements
1.0  0.9 1.2  0.7 0.492
Data are expressed as mean  SD.
LTA Z lateral transperitoneal adrenalectomy; PRA Z posterior
retroperitoneal adrenalectomy.
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Minimally invasive adrenalectomy has been the gold stan-
dard treatment for benign adrenal tumors for the past two
decades.16 Among the different minimally invasive adre-
nalectomy techniques, LTA is the most widely practiced.17
This approach offers a familiar anatomical view and a
large working space in which to manipulate the intra-
abdominal organs. For this reason, LTA was the procedure
used by the study surgeon since he began performing ad-
renalectomies in September 2009. In recent years, howev-
er, many institutes have adopted the PRA technique and
favorable results have been reported.10e13,16e18 The ad-
vantages of PRA include direct exposure of the adrenal
gland without the need for adjacent organ displacement,
and improved visualization and access to the adrenal vein.7
Inspired by the potential advantages of PRA, the study
surgeon began performing PRA in January 2012.
For the patient selection, PRA has limitations. Walz
et al15 recommended a size limit of 7 cm for tumors asso-
ciated with aldosteronism and Cushing’s syndrome, and for
other nonfunctioning tumors. In addition, patients with
extremely obesity or concomitant intra-abdominal pathol-
ogies used to be discouraged for PRA.6 On the contrary, PRA
can be performed safely in patients with a history of
abdominal surgery because the peritoneum does not need
to be breached.16 As studies have reported, the safety of
PRA and the surgeons’ experience is increasing and the
indication has been more liberal.19 Furthermore, PRA using
single port or robotic systems has been successfully per-
formed.20e22 In this study, a more conservative size limit of
5 cm was applied to pheochromocytomas because of the
risk of an intraoperative hypertensive crisis, even though
preoperative a-blockade was used in every patient. PRA
was performed safely in all patients who met these size
requirements. Because the tumor size limit for LTA patients
is more liberal, we excluded patients with tumors outside
the criteria set for PRA to allow a more robust comparison
of surgical outcomes. During the study period, open adre-
nalectomy was performed in 20 patients due to tumorsbeing outside the size criteria or due to suspected
malignancy.
Open conversion was necessary in two cases. One LTA
patient was converted to an open procedure because of
uncontrollable bleeding caused by a tear to the left renal
vein. One PRA patient, who had a history of total pancre-
atectomy and subtotal gastrectomy with jejunal trans-
position due to multiple pancreatic endocrine tumors,
required open conversion because of severe adhesions
around the adjacent liver and inferior vena cava.
There have been concerns that the high CO2 insufflation
required for PRA could stimulate catecholamine secretion
and cause hypertension.23,24 We set the insufflation pres-
sure at 25e30 mmHg, which is reported to be safe for PRA.6
The high pressure is mandatory to create enough retro-
peritoneal space to manipulate the kidney and adrenal
gland; however, the inevitable consequence is significant
hypercarbia, as evidenced by the higher end tidal CO2
levels in PRA patients (36.0  2.9 mmHg vs.
40.8  4.7 mmHg, p < 0.001). However, there were no
complications associated with hypercarbia because it was
controlled by appropriate manipulation of the ventilator
settings. We also evaluated the incidence of intraoperative
hypertensive events to assess whether hypercarbia influ-
enced hemodynamics. A strict definition of an intra-
operative hypertensive event (SBP  170 mmHg) was
applied as per the report of Tonaito.25 Interestingly,
intraoperative hypertensive events occurred only in the LTA
group. The nonincidence of intraoperative hypertensive
events in PRA patients is consistent with previous
studies,9,26,27 and is partially due to the fact that the sur-
geon can avoid direct manipulation of the adrenal gland
when treating pheochromocytoma. Instead, the adrenal
gland is manipulated gently with a cotton ball or the
backside of a clamp.
Dickson et al9 attributed the shorter operation time for
PRA to the directness of the approach to the adrenal
glands, which does not require visceral dissection. In the
present study, the mean operation time for the PRA group
was shorter than that for the LTA group, but the difference
did not reach statistical significance (92.2  27.0 minutes
vs. 78.1  18.9 minutes, p Z 0.054). However, when we
compared the mean operation time of the two approaches
according to tumor location, we found that the time for
PRA was significantly shorter than that for LTA when per-
formed on the right side (109.2 minutes vs. 80.5 minutes,
p Z 0.009); however, there was no difference for the left
side. The difficulty of performing LTA on the right side may
be due to three reasons. First, the right adrenal gland
drains directly into the inferior vena cava via the short
adrenal vein, an anatomic location that makes right LTA
more difficult. Second, mobilization of the liver is more
time consuming than that of the spleen and colon. Third, an
additional port and assistant are needed for adequate
handling of the liver during right adrenalectomy, and this
necessitates additional time (for example, to direct the
assistant during the operation). The difficulty of performing
LTA on the right side was demonstrated by the significantly
longer operation time compared with that for left-sided LTA
(109.2 minutes vs. 83.2 minutes, p Z 0.011).
PRA is associated with less pain than LTA,5,10,11 possibly
due to the shorter operation time and the reduced level of
Comparative study of LTA and PRA 79dissection required.5 Furthermore, PRA requires only three
trocar sites regardless of tumor location, whereas four
trocar sites are needed for a right-sided LTA, leading to
increased pain. During the study period, the patients were
asked if they wanted to use PCA on the previous day of
surgery, and prescribed PCA if they wanted. Therefore, we
could not compare pain scores for all of the patients
because some patients used PCA and they were excluded in
evaluating the VAS. However, the pain score for the PRA
group after the day of operation tended to be lower than
for the LTA group. Considering previous and present
studies, PRA results in less pain for the patient, particularly
if there is no injury to the subcostal nerve, which can cause
severe neuromuscular pain.6,28
Using operation times as a measure, the learning curves
for LTA and PRA are estimated to be 30e50
procedures.29e31 The limited number of cases in the pre-
sent study precludes the determination of the learning
curves for both procedures; however, the mean operation
time for PRA was comparatively shorter than that for LTA.
This suggests that PRA is a viable alternative for surgeons
with experience in laparoscopic adrenalectomy, as has
been previously reported.11,16,32
In the retrospective studies including caseecontrol
studies, the patient selection for specific operative
methods depended on the surgeon’s preference, meaning
that selection bias was inevitable. Specifically, surgeons
may preferentially use the newer technique for easier
cases. The current study is also a retrospective study and
this is a major drawback. However, we could minimize the
surgeon selection bias because patient allocation in each
group was made by time rather than surgeon’s preference.
Another limitation of this study is the possibility that pre-
vious experience of LTA may have reduced the learning
curve required for PRA, thereby resulting in improved
outcomes. However, our study showed that PRA is at least
as effective and safe as LTA in terms of operation time,
blood loss, intraoperative hemodynamics, postoperative
pain, and recovery when performed by a surgeon with
experience in transperitoneal adrenalectomy. Further ran-
domized controlled studies with larger patient populations
are necessary to validate the feasibility and/or superiority
of PRA.
5. Conclusion
PRA provides a direct approach to the adrenal gland and
avoids manipulation of intra-abdominal organs. If a surgeon
has had sufficient experience in LTA, PRA can be performed
safely, resulting in improved outcomes for patients with
benign adrenal tumors.References
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